Clinical performance of the BD onclarity HPV assay using an adjudicated cohort of BD surepath liquid-based cytology specimens

American Journal of Clinical Pathology

Volumn 142, Issue 1, 2014, Pages 43-50

  Wright Jr , Thomas C ^a   Staler, Mark H ^b   Agreda, Patricia M ^c   Beitman, Gerard H ^c   Gutierrez, Erin C ^c   Harris, James M ^c   Koch, Kristopher R ^c   Kuebler, Mindy ^d   LaViers, William D ^c   Legendre Jr , Benjamin L ^d   Leitch, Sharon V ^c   Maus, Courtney E ^c   McMillian, Ray A ^c   Nussbaumer, William A ^c   Palmer, Marcus L R ^c   Porter, Michael J ^c   Richart, Gregory A ^c   Schwab, Ryan J ^c   Vaughan, Laurence M ^c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c BD Diagnostics   (United States)

^d TRANSGENOMIC INC   (United States)

Author keywords

BD onclarity HPV assay; Cervical cancer; High risk HPV; Hybrid capture 2 assay

Indexed keywords

DOUBLE STRANDED DNA;

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DNA BINDING; DNA SEQUENCE; FALSE POSITIVE RESULT; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MIXED INFECTION; MULTICENTER STUDY; PERFORMANCE MEASUREMENT SYSTEM; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRANSPORT MEDIUM; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR KIT;

BD ONCLARITY HPV ASSAY; CERVICAL CANCER; HIGH-RISK HPV; HYBRID CAPTURE 2 ASSAY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 84904551737     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP53KMHNRDICBL     Document Type: Article

References (31)

1. Arbyn M, Sasieni P, Meijer CJ, et al. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24(suppl 3):78-89.
2. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening, Int J Cancer. 2006;119:1095-1101. (Pubitemid 44116919)
3. Ronco G, Biggeri A, Confortini M, et al. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Epidemiol Prev. 2012;36(suppl 1):e1-e72.
4. Murphy J, Kennedy EB, Dunn S, et al. HPV testing in primary cervical screening: a systematic review and meta-analysis. J Obstet Gynaecol. 2012;34:443-452.
5. Rijkaart DC, Berkhof J, van Kemenade FJ, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer. 2012;130:602-610.
6. Cox JT, Castle PE, Behrens CM, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol. 2013;208:e1-e11.
7. Eklund C, Zhou T, Dillner J. Global proficiency study of human papillomavirus genotyping. J Clin Microbiol. 2010;48:4147-4155.
8. Szarewski A, Mesher D, Cadman L, et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol. 2012;50:1867-1873.
9. Cuzick J, Cadman L, Mesher D, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer. 2013;108:908-913.
10. Mesher D, Szarewski A, Cadman L, et al. Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities. Eur J Cancer. 2013;49:2179-2186.
11. Qiagen. Hybrid Capture 2 High-Risk HPV DNA Test Package Insert: L00665 Rev 2. 2007.
12. Felder RA, Foster ML, Lizzi MJ, et al. Process evaluation of a fully automated molecular diagnostics system. J Assoc Lab Automation. 2009;14:262-268.
13. Vaughan L, Chen C, Gutierrez E, et al. Design and development of a novel molecular HPV assay. Abstract presented at the Twenty-Sixth International Papillomavirus Conference and Clinical Workshop; July 5, 2010; Montréal, Canada. Abstract P474.
14. Clontech. NucleoSpin Tissue Kits User Manual. Mountain View, CA: Clontech Laboratories Inc; 2004.PT3629-1 (PR41616).
15. Sundar D-R. Binomial confidence intervals for several parameterizations. binom2009. Version 1.0-5. Available at: http://CRAN.R-project.org/package=binom. Accessed October 2013.
16. Fay M. Two-sided exact tests and matching confidence intervals for discrete data. R J. 2010;2:53-58.
17. JT. Epidemiology tools. R package version 0.5-7. 2012. Available at: http://CRAN.R-project.org/package=epitools. Accessed October 2013.
18. Wright TC Jr, Stoler MH, Behrens CM, et al. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol. 2012;206:46 e1-e11.
19. Agreda PM, Beitman GH, Gutierrez EC, et al. Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media. J Clin Microbiol. 2013;51:2702-2706.
20. Cuzick J, Cadman L, Mesher D, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer. 2013;108:98-113.
21. Castle PE, Solomon D, Wheeler CM, et al. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol. 2008;46:2595-2604.
22. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-1056.
23. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-542.
24. Halfon P, Lindemann ML, Raimondo A, et al. HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test. Arch Virol. 2013;158:1143-1149.
25. Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102:1478-1488.
26. Matsumoto K, Oki A, Furuta R, et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer. 2011;128:2898-2910.
27. Wheeler CM, Hunt WC, Cuzick J, et al. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer. 2013;132:198-207.
28. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621-632. (Pubitemid 46986496)
29. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101-105. (Pubitemid 36897943)
30. Guan P, Howell-Jones R, Li N, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349-2359.
31. Information Centre on Human Papilloma Virus (HPV) and Cancer. Low-risk HPV type prevalence in low and high grade cytology. Available at http://www.hpvcentre.net/dataquery.php. Accessed October 2013.